Literature DB >> 25311547

Novel mouse model of left ventricular pressure overload and infarction causing predictable ventricular remodelling and progression to heart failure.

Carla J Weinheimer1, Ling Lai, Daniel P Kelly, Attila Kovacs.   

Abstract

Mouse surgical models are important tools for evaluating mechanisms of human cardiac disease. The clinically relevant comorbidities of hypertension and ischaemia have not been explored in mice. We have developed a surgical approach that combines transverse aortic constriction and distal left anterior coronary ligation (MI) to produce a gradual and predictable progression of adverse left ventricular (LV) remodelling that leads to heart failure (HF). Mice received either sham, MI alone, transverse aortic constriction alone or HF surgery. Infarct size and LV remodelling were evaluated by serial 2-D echocardiograms. Transverse aortic constriction gradients were measured by the Doppler velocity-time integral ratio between constricted and proximal aortic velocities. At 4 weeks, hearts were weighed and analysed for histology and brain natriuretic peptide, a molecular marker of HF. Echocardiographic analysis of segmental wall motion scores showed similarly small apical infarct sizes in the MI and HF groups at day 1 postsurgery. MI alone showed little change in infarct size over 4 weeks (0.26 ± 0.02 to 0.27 ± 0.04, P = 0.77); however, HF mice showed infarct expansion (0.25 ± 0.06 to 0.39 ± 0.09, P < 0.05). HF mice also showed LV remodelling with increases in LV volumes (1 day = 36.5 ± 5.2 mL, 28 days = 89.1 ± 16.0 mL) versus no significant changes in the other groups. Furthermore, systolic function progressively deteriorated in the HF group only (ejection fraction, 1 day = 55.6 ± 3.6%, 28 days = 17.6 ± 4.1%, P < 0.05) with an increase of brain natriuretic peptide by 3.5-fold. This surgical model of pressure overload in the setting of a small infarction causes progressive deterioration of cardiac structural and functional properties, and provides a clinically relevant tool to study adverse LV remodelling and heart failure.
© 2014 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  echocardiography; experimental model of heart failure; left ventricular hypertrophy; myocardial infarction

Mesh:

Year:  2015        PMID: 25311547      PMCID: PMC4524882          DOI: 10.1111/1440-1681.12318

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  32 in total

1.  Akt1 is required for physiological cardiac growth.

Authors:  Brian DeBosch; Iya Treskov; Traian S Lupu; Carla Weinheimer; Attila Kovacs; Michael Courtois; Anthony J Muslin
Journal:  Circulation       Date:  2006-04-24       Impact factor: 29.690

Review 2.  Healing after myocardial infarction.

Authors:  Georg Ertl; Stefan Frantz
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

Review 3.  From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.

Authors:  Alan H Gradman; Fadi Alfayoumi
Journal:  Prog Cardiovasc Dis       Date:  2006 Mar-Apr       Impact factor: 8.194

4.  Antecedent left ventricular mass and infarct size in ST-elevation myocardial infarction.

Authors:  Zaza Iakobishvili; Vladimir Danicek; Avital Porter; Shula Imbar; David Brosh; Alexander Battler; David Hasdai
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

Review 5.  Induction and analysis of cardiac hypertrophy in transgenic animal models.

Authors:  Marcos E Barbosa; Natalia Alenina; Michael Bader
Journal:  Methods Mol Med       Date:  2005

6.  The 14-3-3tau phosphoserine-binding protein is required for cardiomyocyte survival.

Authors:  Jeffrey M C Lau; Xiaohua Jin; Jie Ren; Joan Avery; Brian J DeBosch; Ilya Treskov; Traian S Lupu; Attila Kovacs; Carla Weinheimer; Anthony J Muslin
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

7.  ACE inhibition decreases postoperative mortality in rats with left ventricular hypertrophy and myocardial infarction.

Authors:  W Linz; G Wiemer; H L Schmidts; W Ulmer; D Ruppert; B A Schölkens
Journal:  Clin Exp Hypertens       Date:  1996-07       Impact factor: 1.749

Review 8.  Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.

Authors:  M A Pfeffer; E Braunwald
Journal:  Circulation       Date:  1990-04       Impact factor: 29.690

9.  Three-dimensional echocardiographic assessment of left ventricular wall motion abnormalities in mouse myocardial infarction.

Authors:  M Scherrer-Crosbie; W Steudel; P R Hunziker; N Liel-Cohen; R Ullrich; W M Zapol; M H Picard
Journal:  J Am Soc Echocardiogr       Date:  1999-10       Impact factor: 5.251

Review 10.  Molecular mechanisms of myocardial remodeling.

Authors:  B Swynghedauw
Journal:  Physiol Rev       Date:  1999-01       Impact factor: 37.312

View more
  22 in total

Review 1.  Why Is Infarct Expansion Such an Elusive Therapeutic Target?

Authors:  William J Richardson; Jeffrey W Holmes
Journal:  J Cardiovasc Transl Res       Date:  2015-09-21       Impact factor: 4.132

Review 2.  Mouse Models of Heart Failure with Preserved or Reduced Ejection Fraction.

Authors:  Natalie A Noll; Hind Lal; W David Merryman
Journal:  Am J Pathol       Date:  2020-04-25       Impact factor: 4.307

3.  Acute Cardiac Unloading and Recovery: Proceedings of the 4th Annual Acute Cardiac Unloading and REcovery (A-CURE) symposium held on 30 August 2019 in Paris, France.

Authors: 
Journal:  Interv Cardiol       Date:  2019-11-18

Review 4.  Relevance of mouse models of cardiac fibrosis and hypertrophy in cardiac research.

Authors:  Vikrant Rai; Poonam Sharma; Swati Agrawal; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2016-10-20       Impact factor: 3.396

5.  Notch-Mediated Epigenetic Regulation of Voltage-Gated Potassium Currents.

Authors:  Aditi Khandekar; Steven Springer; Wei Wang; Stephanie Hicks; Carla Weinheimer; Ramon Diaz-Trelles; Jeanne M Nerbonne; Stacey Rentschler
Journal:  Circ Res       Date:  2016-10-03       Impact factor: 17.367

6.  Mitochondrial protein hyperacetylation in the failing heart.

Authors:  Julie L Horton; Ola J Martin; Ling Lai; Nicholas M Riley; Alicia L Richards; Rick B Vega; Teresa C Leone; David J Pagliarini; Deborah M Muoio; Kenneth C Bedi; Kenneth B Margulies; Joshua J Coon; Daniel P Kelly
Journal:  JCI Insight       Date:  2016-02-25

7.  Rethinking Protein Acetylation in Pressure Overload-Induced Heart Failure.

Authors:  Iain Scott; Michael N Sack
Journal:  Circ Res       Date:  2020-09-24       Impact factor: 17.367

8.  The Failing Heart Relies on Ketone Bodies as a Fuel.

Authors:  Gregory Aubert; Ola J Martin; Julie L Horton; Ling Lai; Rick B Vega; Teresa C Leone; Timothy Koves; Stephen J Gardell; Marcus Krüger; Charles L Hoppel; E Douglas Lewandowski; Peter A Crawford; Deborah M Muoio; Daniel P Kelly
Journal:  Circulation       Date:  2016-01-27       Impact factor: 29.690

9.  TNF receptor-activated factor 2 mediates cardiac protection through noncanonical NF-κB signaling.

Authors:  Sarah Evans; Huei-Ping Tzeng; Deborah J Veis; Scot Matkovich; Carla Weinheimer; Attila Kovacs; Philip M Barger; Douglas L Mann
Journal:  JCI Insight       Date:  2018-02-08

10.  Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure.

Authors:  Carla J Weinheimer; Attila Kovacs; Sarah Evans; Scot J Matkovich; Philip M Barger; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2018-05       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.